Actinium’s Clinical Advisory Board Chairman Joseph Jurcic, MD to Present at the 2014 ASCO Annual Meeting May 20, 2014
Leading Experts in the Field of AML Treatment and Bone Marrow Transplant to Discuss Available Treatment Options and Potential New Opportunities Including Actinium’s Iomab™-B at NY BIO CONference May 13, 2014
Actinium Announces Start of Collaboration to Manufacture IomabTM-B for Phase 3 Clinical Trial and Commercialization May 6, 2014
